Previous 10 | Next 10 |
2023-09-27 16:26:15 ET More on Gritstone bio Gritstone bio (GRTS) Investor Presentation - Slideshow Gritstone: Trying To Pick Itself Up From The COVID Ruins Seeking Alpha’s Quant Rating on Gritstone bio Historical earnings data for Gritstone bio ...
-- 10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus other viral targets with an approved vaccine against COVID-19 -- -- Contract is part of ‘Project NextGen,’ an initiative by the ...
Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of infectious disease vaccines Multi-year, multi-pathogen, option-based deal follows multiple successful prior collabora...
2023-08-09 17:32:16 ET Gritstone bio press release ( NASDAQ: GRTS ): Q2 GAAP EPS of -$0.31 beats by $0.05 . Revenue of $1.96M (-64.2% Y/Y) misses by $0.51M . For further details see: Gritstone bio GAAP EPS of -$0.31 beats by $0.05, revenue of $1.96M misse...
-- Enrollment completed in Phase 2 portion of Phase 2/3 study evaluating GRANITE (personalized cancer vaccine [PCV]) in first-line metastatic microsatellite-stable colorectal cancer (MSS-CRC); preliminary efficacy data expected in 1Q 2024 -- -- Gritstone partnering with Friends of Cance...
EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company has joined the ctMoniTR Project , a collaborative research initiative...
2023-08-01 03:09:04 ET Summary Gritstone bio flew high during the COVID years because of its mRNA COVID vaccine program. With COVID down, GRTS stock has also gone down. Now it survives on its legacy oncology programs, which have some promise. Gritstone bio, Inc. ( ...
2023-07-21 17:17:13 ET Gainers: Gritstone bio ( GRTS ) +4.8% . LexinFintech Holdings ( LX ) +4.3% . AppLovin ( APP ) +2.9% . Latham Group ( SWIM ) +2.6% . Accuray ( ARAY ) +2.5% . Losers: ALX Oncology Holdings ( ALXO ...
-- Potent and durable immunogenicity achieved with low dose self-amplifying mRNA vaccine (samRNA) candidate -- -- Immunity boosted for at least 6 months in previously vaccinated-older adults (administration post-primary series of Vaxzevria ® , Comirnaty ® or Spikevax ...
2023-05-12 12:06:28 ET Gritstone bio ( NASDAQ: GRTS ) stock fell ~10% on Friday after Q1 revenue missed estimates. Net loss widened to -$33.98M, compared to -$28.92M in Q1 2022. Total revenues fell -66% Y/Y to $2.44M. Collaboration and license revenues decline...
News, Short Squeeze, Breakout and More Instantly...
Gritstone Oncology Inc. Company Name:
GRTS Stock Symbol:
NASDAQ Market:
Gritstone Oncology Inc. Website:
2024-06-14 13:15:03 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for GRTS on June 14, 2024 11:01AM ET. The previous analyst recommendation was Market Outperform. GRTS was trading at $0.7575 at issue of the analyst recommendation. The overall analyst ...
2024-05-24 11:30:04 ET B. Riley analyst issues BUY recommendation for GRTS on May 24, 2024 09:31AM ET. The previous analyst recommendation was Buy. GRTS was trading at $0.8039 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
-- Favorable progression-free survival (PFS) trend observed in preliminary data from the randomized Phase 2 study evaluating GRANITE (personalized neoantigen vaccine) in front-line metastatic, microsatellite-stable colorectal cancer (MSS-CRC); mature PFS data expected in the third quarter of 2024...